The Quebec company Linearis, which specializes in the analysis of biomarkers, has just taken over the laboratory was led by Medicago on the Route de l’Église in Quebec.
“We are acquiring Medicago’s main laboratory. Medicago had greenhouses, a factory and clean rooms. We are taking the laboratory that we are going to transform,” said Alexandre Le Bouthillier, President and CEO of Linearis.
Linearis acquired more than 650 scientific instruments and integrated certain Medicago employees, specialists in mass spectrometry, quality assurance and laboratory management, into its team.
The laboratory has an area of 700 square meters. Linearis plans to conduct initial analyzes in the first quarter of 2024.
“The interesting thing about modern technology is that we can do things very quickly. “We are building a laboratory that can produce a lot of data to better understand cancer, diabetes and infectious diseases,” added Mr Le Bouthillier.
Alexandre Le Bouthillier, Chairman and CEO of Linearis. (Photo provided by Linearis) Photo provided by Linearis
The headquarters are in Montreal, but given the opening of this laboratory, it would not be surprising if the company moved its premises to Quebec.
The new laboratory uses an analytical platform that combines artificial intelligence and biomarkers to make advances in the detection, treatment, monitoring and prevention of various diseases.
“I lost my father to cancer. Technologies never advance fast enough. That’s what we want to do in this lab.”
Linearis’ work is aimed at biobanks, researchers, clinical research organizations and biopharmaceutical companies.
With the closure of the Medicago facilities in Quebec, a business opportunity arose for Linearis, which rose to the challenge.
“Building a laboratory can be very expensive. It takes time. “The opportunity had to be seized,” he added.
To carry out its analyses, the laboratory uses serum, blood or plasma.
The announcement was made on Tuesday during the Quebec Health Industry Forum held at the Voltigeurs Military Armory in Quebec.
The agreement has been negotiated since March last year. About ten people will work in this laboratory. The amount of the investment was not disclosed.
“What is important for us is that we were able to save this laboratory, otherwise it would have been converted into office space. It would have been very sad,” added Mr Le Bouthillier.
Can you share information about this story?
Write to us or call us directly at 1 800-63SCOOP.